Modulation of human T-type calcium channels by synthetic cannabinoid receptor agonists in vitro

Adamowicz, 2016, Fatal intoxication with synthetic cannabinoid MDMB-CHMICA, Forensic Sci. Int., 261, e5, 10.1016/j.forsciint.2016.02.024 Babi, 2017, A spicy status: synthetic cannabinoid (spice) use and new-onset refractory status epilepticus—a case report and review of the literature, SAGE Open Med. Case Rep., 5 Backberg, 2017, Analytically confirmed intoxications involving MDMB-CHMICA from the STRIDA Project, J. Med. Toxicol., 13, 52, 10.1007/s13181-016-0584-2 Banister, 2018, The chemistry and pharmacology of synthetic cannabinoid receptor agonists as new psychoactive substances: origins, Handb. Exp. Pharmacol., 252, 165, 10.1007/164_2018_143 Banister, 2016, Pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues, ACS Chem. Neurosci., 7, 1241, 10.1021/acschemneuro.6b00137 Banister, 2015, Pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA, ACS Chem. Neurosci., 6, 1546, 10.1021/acschemneuro.5b00112 Bender, 2012, Control of firing patterns through modulation of axon initial segment T-type calcium channels, J. Physiol., 590, 109, 10.1113/jphysiol.2011.218768 Bladen, 2015, Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects, ACS Chem. Neurosci., 6, 277, 10.1021/cn500206a Bladen, 2012, Common mechanisms of drug interactions with sodium and T-type calcium channels, Mol. Pharmacol., 82, 481, 10.1124/mol.112.079715 Bourinet, 2005, Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception, EMBO J., 24, 315, 10.1038/sj.emboj.7600515 Casillas-Espinosa, 2019, Disease-modifying effects of a novel T-type calcium channel antagonist, Z944, in a model of temporal lobe epilepsy, Prog. Neurobiol., 182, 10.1016/j.pneurobio.2019.101677 Chemin, 2001, Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide, EMBO J., 20, 7033, 10.1093/emboj/20.24.7033 Choi, 2007, Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels, Gene Brain Behav., 6, 425, 10.1111/j.1601-183X.2006.00268.x David, 2010, Splice-variant changes of the Ca(V)3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development, Channels, 4, 375, 10.4161/chan.4.5.12874 EMCDDA, 2017 Feng, 2003, Determinants of inhibition of transiently expressed voltage-gated calcium channels by omega-conotoxins GVIA and MVIIA, J. Biol. Chem., 278, 20171, 10.1074/jbc.M300581200 Franz, 2017, Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples, Drug Test. Anal., 9, 744, 10.1002/dta.2049 Gilmore, 2012, Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT, Br. J. Pharmacol., 167, 1076, 10.1111/j.1476-5381.2012.02047.x Hermanns-Clausen, 2018, Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA, Clin. Toxicol., 56, 404, 10.1080/15563650.2017.1393082 Heron, 2007, Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants, Ann. Neurol., 62, 560, 10.1002/ana.21169 Hill, 2016, Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification of Novel psychoActive substances (IONA) study, Clin. Toxicol., 54, 638, 10.1080/15563650.2016.1190980 Huestis, 2007, Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users, Psychopharmacology (Berl), 194, 505, 10.1007/s00213-007-0861-5 Jagodic, 2008, Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve, J. Neurophysiol., 99, 3151, 10.1152/jn.01031.2007 Kampa, 2007, Dendritic mechanisms controlling spike-timing-dependent synaptic plasticity, Trends Neurosci., 30, 456, 10.1016/j.tins.2007.06.010 Khosravani, 2005, Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy, Ann. Neurol., 57, 745, 10.1002/ana.20458 Klumpers, 2013, Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects, Br. J. Clin. Pharmacol., 76, 846, 10.1111/bcp.12141 Knapman, 2013, A continuous, fluorescence-based assay of mu-opioid receptor activation in AtT-20 cells, J. Biomol. Screen, 18, 269, 10.1177/1087057112461376 Lee, 2014, Z944: a first in class T-type calcium channel modulator for the treatment of pain, J. Peripher. Nerv. Syst., 19, S11, 10.1111/jns.12080_2 Longworth, 2017, Synthesis and pharmacological profiling of the metabolites of synthetic cannabinoid drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA, ACS Chem. Neurosci., 8, 1673, 10.1021/acschemneuro.7b00116 Martin, 2014, Locating the route of entry and binding sites of benzocaine and phenytoin in a bacterial voltage gated sodium channel, PLoS Comput. Biol., 10, 10.1371/journal.pcbi.1003688 Micale, 2019, The cannabinoid CB1 antagonist TM38837 with limited penetrance to the brain shows reduced fear-promoting effects in mice, Front. Pharmacol., 10, 207, 10.3389/fphar.2019.00207 Najafi, 2016, Severe clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA: a report from the Identification of Novel psychoActive substance study (IONA), Clin. Toxicol., 54 Ono, 2010, Cardiac T-type Ca(2+) channels in the heart, J. Mol. Cell. Cardiol., 48, 65, 10.1016/j.yjmcc.2009.08.021 Perez-Reyes, 2003, Molecular physiology of low-voltage-activated t-type calcium channels, Physiol. Rev., 83, 117, 10.1152/physrev.00018.2002 Ross, 2009, Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine, Br. J. Pharmacol., 156, 740, 10.1111/j.1476-5381.2008.00072.x Ross, 2008, Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol, J. Biol. Chem., 283, 16124, 10.1074/jbc.M707104200 Sachdev, 2019, In vitro determination of the CB1 efficacy of illicit synthetic cannabinoids, Br. J. Pharmacol., 176, 4653, 10.1111/bph.14829 Sheets, 2008, Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine, J. Pharmacol. Exp. Therapeut., 326, 89, 10.1124/jpet.107.133413 Tait, 2016, A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment, Clin. Toxicol., 54, 1, 10.3109/15563650.2015.1110590 Trecki, 2015 You, 2011, Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands, Mol. Pain, 7, 89, 10.1186/1744-8069-7-89 Zamponi, 2010, Role of voltage-gated calcium channels in epilepsy, Pflügers Archiv, 460, 395, 10.1007/s00424-009-0772-x Zhao, 2019, Cryo-EM structures of apo and antagonist-bound human Cav3.1, Nature, 576, 492, 10.1038/s41586-019-1801-3